Literature DB >> 35708800

The role of bone marrow adipocytes in cancer progression: the impact of obesity.

Marine Hernandez1,2, Sauyeun Shin1,2, Catherine Muller3,4, Camille Attané5,6.   

Abstract

Bone marrow adipose tissues (BMATs) and their main cellular component, bone marrow adipocytes (BMAds), are found within the bone marrow (BM), which is a niche for the development of hematological malignancies as well as bone metastasis from solid tumors such as breast and prostate cancers. In humans, BMAds are present within the hematopoietic or "red" BMAT and in the "yellow" BMAT where they are more densely packed. BMAds are emerging as new actors in tumor progression; however, there are many outstanding questions regarding their precise role. In this review, we summarized our current knowledge regarding the development, distribution, and regulation by external stimuli of the BMATs in mice and humans and addressed how obesity could affect these traits. We then discussed the specific metabolic phenotype of BMAds that appear to be different from "classical" white adipocytes, since they are devoid of lipolytic function. According to this characterization, we presented how tumor cells affect the in vitro and in vivo phenotype of BMAds and the signals emanating from BMAds that are susceptible to modulate tumor behavior with a specific emphasis on their metabolic crosstalk with cancer cells. Finally, we discussed how obesity could affect this crosstalk. Deciphering the role of BMAds in tumor progression would certainly lead to the identification of new targets in oncology in the near future.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bone marrow adipocytes; Cancer progression; Metabolic crosstalk; Obesity

Mesh:

Year:  2022        PMID: 35708800     DOI: 10.1007/s10555-022-10042-6

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.237


  48 in total

Review 1.  Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors.

Authors:  Ernst Lengyel; Liza Makowski; John DiGiovanni; Mikhail G Kolonin
Journal:  Trends Cancer       Date:  2018-04-05

Review 2.  Anatomical, Physiological, and Functional Diversity of Adipose Tissue.

Authors:  Rachel K Zwick; Christian F Guerrero-Juarez; Valerie Horsley; Maksim V Plikus
Journal:  Cell Metab       Date:  2018-01-09       Impact factor: 27.287

Review 3.  Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome.

Authors:  C Ronald Kahn; Guoxiao Wang; Kevin Y Lee
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

Review 4.  Adipokines in health and disease.

Authors:  Mathias Fasshauer; Matthias Blüher
Journal:  Trends Pharmacol Sci       Date:  2015-05-25       Impact factor: 14.819

Review 5.  Adipokines in inflammation and metabolic disease.

Authors:  Noriyuki Ouchi; Jennifer L Parker; Jesse J Lugus; Kenneth Walsh
Journal:  Nat Rev Immunol       Date:  2011-01-21       Impact factor: 53.106

Review 6.  Drilling for Oil: Tumor-Surrounding Adipocytes Fueling Cancer.

Authors:  Camille Attané; Catherine Muller
Journal:  Trends Cancer       Date:  2020-03-26

7.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 8.  Adipose tissue and adipocytes support tumorigenesis and metastasis.

Authors:  Kristin M Nieman; Iris L Romero; Bennett Van Houten; Ernst Lengyel
Journal:  Biochim Biophys Acta       Date:  2013-03-14

Review 9.  Adiposity and cancer risk: new mechanistic insights from epidemiology.

Authors:  Andrew G Renehan; Marcel Zwahlen; Matthias Egger
Journal:  Nat Rev Cancer       Date:  2015-08       Impact factor: 60.716

Review 10.  Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics.

Authors:  Pauline Morigny; Jeremie Boucher; Peter Arner; Dominique Langin
Journal:  Nat Rev Endocrinol       Date:  2021-02-24       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.